Drugs / L-boronophenylalanine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07058116 | May → Nov 2025 overdue | head and neck carcinoma | Neutron Therapeutics, LLC | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-boronophenylalanine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07058116 ↗ |
| Known as | L-BPA | “L-boronophenylalanine (L-BPA) will be purchased from a commercial source.” NCT07058116 ↗ |